Sartorius Forms Partnership with SPARTA Biodiscovery on Novel Nanoparticle Analysis Platform

SPARTA technology to accelerate the development, manufacture and quality control of nanoparticles used for gene therapies, vaccines, and cancer drugs The ...

September 29, 2023 | Friday | News
QIAGEN Expands AI in NGS Software for Clinical Exome Completeness

QIAGEN announced  the expansion of its clinical decision support software, QIAGEN Clinical Insight Interpret (QCI Interpret), to include artificial in...

September 29, 2023 | Friday | News
X-Chem and Structural Genomics Consortium Partner to Unlock Human Proteome and Promote Open Science

The goal is to generate DNA-encoded library (DEL) screening data for large numbers of under-addressed proteins in the human proteome — ultimately all...

September 29, 2023 | Friday | News
Syntropy Announces Collaboration with Evidium to Advance Data-Centric Healthcare

The alliance will address clinical research and practice challenges related to data quality Enabled through the Syntropy and Evidium platforms, their ca...

September 28, 2023 | Thursday | News
Charles River Unveils Lentivation Platform to Expedite LVV-based Gene Therapy Manufacturing

Charles River Laboratories International, Inc.  announced the launch of its lentiviral vector (LVV) manufacturing platform, Lentivation™. The pl...

September 27, 2023 | Wednesday | News
Revvity Expands Access to Base Editing Technology With Aim to Accelerate Discovery to Cure

Launch of Pin-pointTM base editing reagents improves access to new-generation editing technology Access to the Pin-point system now bridges discovery, p...

September 27, 2023 | Wednesday | News
Merck Becomes First CTDMO to Offer Comprehensive mRNA Development and Manufacturing Services

New sites at Darmstadt and Hamburg complement Merck’s global integrated mRNA service network with pre-clinical to commercial capabilities Company&...

September 27, 2023 | Wednesday | News
Amphista Therapeutics Achieves First Milestone in Second Discovery Programme with Bristol Myers Squibb

Amphista Therapeutics (“the Company” or “Amphista”), a leader in next generation targeted protein degradation (TPD) approaches, tod...

September 27, 2023 | Wednesday | News
Mdxhealth Collaborates with University of Oxford to Study GPS Test's Link to Post-Treatment Prostate Cancer Progression

MDxHealth SA (NASDAQ/Euronext: MDXH), a leading commercial-stage precision diagnostics company, today announced a research collaboration with the Universit...

September 27, 2023 | Wednesday | News
Novartis' Lutathera® Shows Significant Progression-Free Survival in GEP-NETs

Phase III NETTER-2 trial met primary endpoint of improvement in progression-free survival (PFS) and key secondary endpoint of objective response rate (OR...

September 26, 2023 | Tuesday | News
Alvotech Announces Approval in Japan of AVT04 (ustekinumab), a Biosimilar to Stelara®

“We are thrilled to receive marketing approval for AVT04 in Japan, which will be Alvotech’s second marketed biosimilar,” said Robert Wess...

September 26, 2023 | Tuesday | News
Valo Health and Novo Nordisk to Collaborate on AI-Driven Cardiometabolic Treatments

Novo Nordisk licenses three preclinical drug discovery programmes in cardiovascular diseases discovered and developed by Valo using the Opal Computational ...

September 26, 2023 | Tuesday | News
QIAGEN Enhances QIAwave Portfolio with Eco-Friendly Extraction Kits

QIAGEN announced the extension of its eco-friendlier QIAwave product line with the addition of two new nucleic acid extraction kits: the QIAwave RNeasy Plu...

September 26, 2023 | Tuesday | News
Basel's Biotech Renaissance: Pioneering Gene Therapy and Beyond

In the world of biotechnology and pharmaceuticals, innovation is the lifeblood of progress. And in the picturesque Basel area, this spirit of innovation is...

September 25, 2023 | Monday | Reports

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close